Advances in Eicosanoid Research

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry, Biotechnology
Cover of the book Advances in Eicosanoid Research by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783662040478
Publisher: Springer Berlin Heidelberg Publication: March 14, 2013
Imprint: Springer Language: English
Author:
ISBN: 9783662040478
Publisher: Springer Berlin Heidelberg
Publication: March 14, 2013
Imprint: Springer
Language: English

Over the last few years, we have witnessed tremendous progress in the field of eicosanoids and their therapeutic applications. Receptor an­ tagonists for leukotrienes have been tested as anti-inflammatories and are on the market as a treatment for asthma. Receptor agonists for pro­ stacyclin are being tested for the treatment of peripheral vascular dis­ ease, and selective inhibitors of cyclooxygenase type II were just ap­ proved for the treatment of rheumatoid arthritis. All these developments are the culmination of many years and man-hours of careful research. The field has now entered an upswing that will result in novel thera­ peutic applications within the next 10 years. New molecules and me­ diators have been identified, new enzymes and pathways elucidated and new therapeutic approaches have emerged. The concept of ei­ cosanoids as "pro-inflammatory" molecules is being challenged, and their role as regulators is increasingly recognized. In fact, some of these molecules may be important endogenous anti-inflammatory agents.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Over the last few years, we have witnessed tremendous progress in the field of eicosanoids and their therapeutic applications. Receptor an­ tagonists for leukotrienes have been tested as anti-inflammatories and are on the market as a treatment for asthma. Receptor agonists for pro­ stacyclin are being tested for the treatment of peripheral vascular dis­ ease, and selective inhibitors of cyclooxygenase type II were just ap­ proved for the treatment of rheumatoid arthritis. All these developments are the culmination of many years and man-hours of careful research. The field has now entered an upswing that will result in novel thera­ peutic applications within the next 10 years. New molecules and me­ diators have been identified, new enzymes and pathways elucidated and new therapeutic approaches have emerged. The concept of ei­ cosanoids as "pro-inflammatory" molecules is being challenged, and their role as regulators is increasingly recognized. In fact, some of these molecules may be important endogenous anti-inflammatory agents.

More books from Springer Berlin Heidelberg

Cover of the book Linguistic Units and Items by
Cover of the book The Cordilleran Miogeosyncline in North America by
Cover of the book Intrinsic Neuronal Organization of the Vestibular Nuclear Complex in the Cat by
Cover of the book Stochastic Calculus with Infinitesimals by
Cover of the book Some Topics in Algebra by
Cover of the book Betriebliche Bildung by
Cover of the book Qualitäts- und Risikomanagement im Gesundheitswesen by
Cover of the book Hydrofunctionalization by
Cover of the book Proceedings of The Eighth International Conference on Bio-Inspired Computing: Theories and Applications (BIC-TA), 2013 by
Cover of the book Applied Ecology and Human Dimensions in Biological Conservation by
Cover of the book Key Aspects of German Employment and Labour Law by
Cover of the book Evolution 2.0 by
Cover of the book Geobiotechnology II by
Cover of the book Current Problems in the Epidemiology of Cancer and Lymphomas by
Cover of the book Surgery of the Thyroid and Parathyroid Glands by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy